Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2022-03-24 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges regarding requests received for loss of share certificates and issuance of duplicate share certificates. It references compliance with SEBI regulations and includes details of shareholders and certificate numbers. There is no financial data, earnings information, management discussion, or report publication. The document is a regulatory announcement related to share certificate loss and replacement, which does not fit into financial reports or management reports categories. It is a regulatory filing informing exchanges about shareholder requests under SEBI Listing Obligations. The document length is under 5,000 characters and is an announcement rather than a report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-03-24 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a sub-license agreement between Strides Pharma Science Limited and Medicines Patent Pool (MPP) to commercialize a generic version of Pfizer's COVID-19 oral treatment. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about a business partnership and product commercialization, not a financial report, earnings release, or regulatory filing. The document is relatively short (4912 characters) and serves as a public relations communication. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other specific categories.
2022-03-21 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a collaboration between Akston Biosciences and Biolexis to launch a COVID-19 vaccine. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about a business collaboration and product launch, not a financial report or regulatory filing. The document is not an earnings release, annual report, or any other financial report type. It is a general corporate press release, which fits best under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2022-03-17 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding a request for issuance of duplicate share certificates due to loss of original certificates. It references SEBI regulations and a SEBI circular about the procedure for issuing duplicate certificates. The content focuses on shareholder share certificate issues and procedural compliance rather than financial results, management changes, or other report types. The document length is about 3,055 characters, which is relatively short and primarily an announcement or notification. It does not contain financial statements, earnings data, or detailed management discussion. It is not a report but an official regulatory announcement related to share certificates. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement that does not fit other specific categories.
2022-03-16 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of newspaper advertisements related to an Extraordinary General Meeting (EGM) scheduled for April 7, 2022. It mentions compliance with SEBI regulations and the dispatch of the EGM notice and e-voting information. The content is an announcement about the publication of meeting notices and voting information, not the meeting materials themselves or voting results. The document length is short (1358 characters), and it serves as a regulatory announcement rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance announcement related to shareholder meetings.
2022-03-15 English
Extra Ordinary Meeting
Capital/Financing Update Classification · 95% confidence The document is a detailed communication from Strides Pharma Science Limited to stock exchanges and shareholders regarding a proposed preferential issue of equity warrants. It includes information about the board's approval, the terms of the preferential issue, the intent of the promoter group to increase their stake, and the notice of an Extraordinary General Meeting (EGM) to approve these matters. The document contains detailed disclosures under SEBI regulations, the notice of the EGM, and resolutions to be passed at the EGM. It is not a full financial report, earnings release, or audit report. It is an official announcement related to capital raising through a preferential issue and the convening of an EGM to approve it. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not merely an announcement of a report but a substantive update on financing activities.
2022-03-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.